AAAAAA
Results:
1-9
|
Results: 9
Authors:
Althaus, M
de Mey, C
Ezan, E
Ciecko-Michalska, I
Kostka-Trabkal, E
Goszcz, A
Retzow, A
Citation: M. Althaus et al., Plasma and urine, pharmacokinetics of the dopamine agonist alpha-dihydroergocryptine in patients with hepatic dysfunction, INT J CL PH, 39(2), 2001, pp. 67-74
Authors:
Minea, D
Varga, I
Falup-Pecurariu, C
de Mey, C
Retzow, A
Althaus, M
Citation: D. Minea et al., Influence of the dopamine agonist alpha-dihydroergocryptine on the pharmacokinetics of levodopa in patients with Parkinson's disease, CLIN NEUROP, 24(4), 2001, pp. 235-238
Authors:
de Mey, C
Althaus, M
Ezan, E
Retzow, A
Citation: C. De Mey et al., Erythromycin increases plasma concentrations of alpha-dihydroergocryptine in humans, CLIN PHARM, 70(2), 2001, pp. 142-148
Authors:
Wangemann, M
Retzow, A
Mazur, D
Vens-Cappell, B
Citation: M. Wangemann et al., Study on the dose proportionality of the pharmacokinetics of sustained release sodium valproate, INT J CL PH, 38(8), 2000, pp. 395-401
Authors:
Muller-Oerlinghausen, B
Retzow, A
Henn, FA
Giedke, H
Walden, J
Citation: B. Muller-oerlinghausen et al., Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: A prospective, randomized, double-blind, placebo-controlled, multicenter study, J CL PSYCH, 20(2), 2000, pp. 195-203
Authors:
Althaus, M
Retzow, A
Castell, JV
Gomez-Lechon, MJ
Amalou, Z
Rose, T
Appel, K
Citation: M. Althaus et al., In vitro identification of the cytochrome P450 isoform responsible for themetabolism of alpha-dihydroergocryptine, XENOBIOTICA, 30(11), 2000, pp. 1033-1045
Authors:
Retzow, A
Althaus, M
de Mey, C
Mazur, D
Vens-Cappell, B
Citation: A. Retzow et al., Study on the interaction of the dopamine agonist alpha-dihydroergocryptinewith the pharmacokinetics of digoxin, ARZNEI-FOR, 50(7), 2000, pp. 591-596
Authors:
Wangemann, M
Retzow, A
Vens-Cappell, B
Citation: M. Wangemann et al., Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate, INT J CL PH, 37(2), 1999, pp. 100-108
Authors:
Wangemann, M
Retzow, A
Evers, G
Mazur, D
Schug, B
Blume, H
Citation: M. Wangemann et al., Bioavailability study of two carbamazepine containing sustained release formulations after multiple oral dose administration, ARZNEI-FOR, 48(12), 1998, pp. 1131-1137
Risultati:
1-9
|